Polycystic Ovary Syndrome
"Polycystic Ovary Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading.
Descriptor ID |
D011085
|
MeSH Number(s) |
C04.182.612.765 C13.351.500.056.630.580.765 C19.391.630.580.765
|
Concept/Terms |
Polycystic Ovary Syndrome- Polycystic Ovary Syndrome
- Ovary Syndrome, Polycystic
- Syndrome, Polycystic Ovary
- Stein-Leventhal Syndrome
- Stein Leventhal Syndrome
- Syndrome, Stein-Leventhal
- Sclerocystic Ovarian Degeneration
- Ovarian Degeneration, Sclerocystic
- Sclerocystic Ovary Syndrome
- Polycystic Ovarian Syndrome
- Ovarian Syndrome, Polycystic
- Polycystic Ovary Syndrome 1
|
Below are MeSH descriptors whose meaning is more general than "Polycystic Ovary Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Polycystic Ovary Syndrome".
This graph shows the total number of publications written about "Polycystic Ovary Syndrome" by people in UAMS Profiles by year, and whether "Polycystic Ovary Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2024 | 1 | 0 | 1 | 2023 | 1 | 0 | 1 | 2020 | 1 | 0 | 1 | 2018 | 1 | 1 | 2 | 2017 | 1 | 1 | 2 | 2015 | 0 | 1 | 1 | 2013 | 1 | 0 | 1 | 2009 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Polycystic Ovary Syndrome" by people in Profiles over the past ten years.
-
Fordham TM, Morelli NS, Garcia-Reyes Y, Ware MA, Rahat H, Sundararajan D, Fuller KNZ, Severn C, Pyle L, Malloy CR, Jin ES, Parks EJ, Wolfe RR, Cree MG. Metabolic effects of an essential amino acid supplement in adolescents with PCOS and obesity. Obesity (Silver Spring). 2024 04; 32(4):678-690.
-
Maldonado SS, Cedars MI, Yates KP, Wilson LA, Gill R, Terrault NA, Suzuki A, Sarkar MA. Antimullerian Hormone, a Marker of Ovarian Reserve, Is Protective Against Presence and Severity of NASH in Premenopausal Women. Clin Gastroenterol Hepatol. 2024 02; 22(2):339-346.e5.
-
Alkhuriji AF, Al Omar SY, Babay ZA, El-Khadragy MF, Mansour LA, Alharbi WG, Khalil MI. Association of IL-1?, IL-6, TNF-a, and TGF?1 Gene Polymorphisms with Recurrent Spontaneous Abortion in Polycystic Ovary Syndrome. Dis Markers. 2020; 2020:6076274.
-
Singh A, Choubey M, Bora P, Krishna A. Adiponectin and Chemerin: Contrary Adipokines in Regulating Reproduction and Metabolic Disorders. Reprod Sci. 2018 10; 25(10):1462-1473.
-
Singh A, Bora P, Krishna A. Systemic adiponectin treatment reverses polycystic ovary syndrome-like features in an animal model. Reprod Fertil Dev. 2018 Mar; 30(4):571-584.
-
Geer EB, Shafiq I, Gordon MB, Bonert V, Ayala A, Swerdloff RS, Katznelson L, Lalazar Y, Manuylova E, Pulaski-Liebert KJ, Carmichael JD, Hannoush Z, Surampudi V, Broder MS, Cherepanov D, Eagan M, Lee J, Said Q, Neary MP, Biller BMK. BIOCHEMICAL CONTROL DURING LONG-TERM FOLLOW-UP OF 230 ADULT PATIENTS WITH CUSHING DISEASE: A MULTICENTER RETROSPECTIVE STUDY. Endocr Pract. 2017 Aug; 23(8):962-970.
-
Singh A, Bora P, Krishna A. Direct action of adiponectin ameliorates increased androgen synthesis and reduces insulin receptor expression in the polycystic ovary. Biochem Biophys Res Commun. 2017 07 01; 488(3):509-515.
-
Rochlani Y, Pothineni NV, Mehta JL. Metabolic Syndrome: Does it Differ Between Women and Men? Cardiovasc Drugs Ther. 2015 Aug; 29(4):329-38.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|